|
9:00 – 11:30 |
Short Course: Practice of Pharmacoeconomics Study |
|
9:00～9:20 |
Introduction
Hiroyuki Sakamaki (Meijo Univ) |
|
9:20～10:00 |
Case Study in Company：Cost/ＱＯＬ Data Collection
Shuichi Yajima (Taiho Pharm Co, LTD)
|
|
10:00～10:40 |
Case Study in Company：An Example of Modeling
Makoto Kobayashi (Crecon R&D)
|
|
10:40～11:00 |
Discussion |
| 11:00～11:20 |
Concluding Remarks
Shunya Ikeda (International Univ of Health and Welfare) |
| 11:30 – 12:30 |
ISPOR Japan Chapter: Executive Committee Meeting
|
| 13:00 – 13:10 |
President Remarks from Japan
Chapter-
Isao Kamae（Kobe Univ） |
| 13:10 – 13:50 |
“ISPOR Directives & Initiatives:
Focusing on Japan”
|
| |
Invited Speaker Dr. Marilyn Dix Smith (ISPOR
Founding Executive Director): |
| 13:50 – 15:00 |
“Pharmacoeconomics,
Patient-reported Outcomes: Issues and Controversies” |
| |
Invited Speaker: Professor William McGhan (ISPOR Founding
President): |
| 15:00 – 15:10 |
Break |
| 15:20 – 16:00 |
Panel Session: Discussing opportunities in Japan for ISPOR
research and education training |
| |
Moderator: Isao Kamae (Kobe Univ)
Japan; Naoki Ikegami（Keio Univ, Toshio Nagae (York Pharma)
USA; Professor William McGhan, Dr. Marilyn Dix Smith
|
| 16:00 – 16:40 |
Special Workshop: US FDA PRO Guidance＜Japanese Edition＞ |
| |
Moderator: Koujiro Shimozuma（Univ of Marketing and
Distribution Sciences
Shunya Ikeda（International Univ of Health and Welfare, Hiroyuki Sakamaki（Meijo Univ),
Naohiro Nakahara（Eli Lilly Japan), Takashi Hukuda（Univ of Tokyo, IHEP）
|
| 16:40 – 17:10 |
ISPOR Japan Chapter: General Assembly
|
